This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chénais, B. Articles by Blank, V. Search for Related Content PubMed PubMed Citation Articles by Chénais, B. Articles by Blank, V. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH

Functional and Placental Expression Analysis of the Human NRF3 Transcription Factor

Lady Davis Institute for Medical Research (B.C., A.D., W.M., V.Bl.) and Department of Medicine (V.Bl.), McGill University, Montréal, Québec, Canada, H3T 1E2; and Division of Stomatology (K.R.-H., V.Be., S.J.F.), Obstetrics (S.J.F.), Gynecology and Reproductive Sciences (S.J.F.), Pharmaceutical Chemistry (S.J.F.) and Anatomy (S.J.F.), University of California, San Francisco, California 94143-0512

Address all correspondence and requests for reprints to: Volker Blank, Lady Davis Institute for Medical Research, 3755 Côte-Sainte-Catherine Road, Montréal, Québec, Canada H3T 1E2. E-mail: volker.blank{at}mcgill.ca.

Members of the Maf protooncogene and cap’n’ collar families of basic-leucine zipper transcription factors play important roles in development, differentiation, oncogenesis, and stress signaling. In this study, we performed an in vivo protein-protein interaction screen to search for novel partners of the small Maf proteins. Using full-length human MAFG protein as bait, we identified the human basic-leucine zipper protein NRF3 [NF-E2 (nuclear factor erythroid 2)-related factor 3] as an interaction partner. Transfection studies confirmed that NRF3 is able to dimerize with MAFG. The resulting NRF3/MAFG heterodimer recognizes nuclear factor-erythroid 2/Maf recognition element-type DNA-binding motifs. Functional analysis revealed the presence of a strong transcriptional activation domain in the center region of the NRF3 protein. We found that NRF3 transcripts are present in placental chorionic villi from at least week 12 of gestation on through term. In particular, NRF3 is highly expressed in primary placental cytotrophoblasts, but not in placental fibroblasts. The human choriocarcinoma cell lines BeWo and JAR, derived from trophoblastic tumors of the placenta, also strongly express NRF3 transcripts. We generated a NRF3-specific antiserum and identified NRF3 protein in placental choriocarcinoma cells. Furthermore, we showed that NRF3 transcript and protein levels are induced by TNF- in JAR cells. Our functional studies suggest that human NRF3 is a potent transcriptional activator. Finally, our expression and induction analyses hint at a possible role of Nrf3 in placental gene expression and development.